Cop 1 therapy for multiple sclerosis.
Weiner
H L
HL
D002986:Clinical Trials as Topic; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D012107:Research Design
D010455:Peptides; C021759:(T,G)-A-L